{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:43:06Z","timestamp":1793086986696,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous studies have investigated metabolite alterations resulting from pharmacological treatment in depression models although few quantitative studies explored metabolites exhibiting constant alterations. This study aimed to identify consistently dysregulated metabolites across such studies using a knowledgebase-driven approach. This study was based on 157 studies that identified an assembly of 2757 differential metabolites in the brain, blood, urine, liver, and feces samples of depression models with pharmacological medication. The use of a vote-counting approach to identify consistently upregulated and downregulated metabolites showed that serotonin, dopamine, norepinephrine, gamma-aminobutyric acid, anandamide, tryptophan, hypoxanthine, and 3-methoxytyramine were upregulated in the brain, while quinolinic acid, glutamic acid, 5-hydroxyindoleacetic acid, myo-inositol, lactic acid, and the kynurenine\/tryptophan ratio were downregulated. Circulating levels of trimethylamine <jats:italic>N<\/jats:italic>-oxide, isoleucine, leucine, tryptophan, creatine, serotonin, valine, betaine, and low-density lipoprotein were elevated. In contrast, levels of alpha-<jats:sc>d<\/jats:sc>-glucose, lactic acid, <jats:italic>N<\/jats:italic>-acetyl glycoprotein, glutamine, beta-<jats:sc>d<\/jats:sc>-glucose, corticosterone, alanine, phenylacetylglycine, glycine, high-density lipoprotein, arachidonic acid, myo-inositol, allantoin, and taurine were decreased. Moreover, 12 metabolites in urine and nine metabolites in the liver were dysregulated after treatment. Pharmacological treatment also increased fecal levels of butyric acid, acetic acid, propionic acid, and isovaleric acid. Collectively, metabolite disturbances induced by depression were reversed by pharmacological treatment. Pharmacological medication reversed the reduction of brain neurotransmitters caused by depression, modulated disturbance of the tryptophan-kynurenine pathway and inflammatory activation, and alleviated abnormalities of amino acid metabolism, energy metabolism, lipid metabolism, and gut microbiota-derived metabolites.<\/jats:p>","DOI":"10.1038\/s41398-022-01947-5","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T09:05:04Z","timestamp":1651223104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Effects of pharmacological treatment on metabolomic alterations in animal models of depression"],"prefix":"10.1038","volume":"12","author":[{"given":"Juncai","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-3972","authenticated-orcid":false,"given":"Dongfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6648-4461","authenticated-orcid":false,"given":"Xiaogang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-6048","authenticated-orcid":false,"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"1947_CR1","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1016\/S2468-2667(21)00047-5","volume":"6","author":"J Arias-de la Torre","year":"2021","unstructured":"Arias-de la Torre J, Vilagut G, Ronaldson A, Serrano-Blanco A, Mart\u00edn V, Peters M, et al. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health. 2021;6:e729\u201338.","journal-title":"Lancet Public Health"},{"key":"1947_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75:336\u201346.","journal-title":"JAMA Psychiatry"},{"key":"1947_CR3","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1017\/S0033291720001087","volume":"51","author":"J Das-Munshi","year":"2021","unstructured":"Das-Munshi J, Chang CK, Dregan A, Hatch SL, Morgan C, Thornicroft G, et al. How do ethnicity and deprivation impact on life expectancy at birth in people with serious mental illness? Observational study in the UK. Psychol Med. 2021;51:2581\u20139.","journal-title":"Psychol Med."},{"key":"1947_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","volume":"39","author":"PE Greenberg","year":"2021","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics. 2021;39:653\u201365.","journal-title":"Pharmacoeconomics"},{"key":"1947_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-0997-0","volume":"21","author":"J Rehm","year":"2019","unstructured":"Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21:10.","journal-title":"Curr Psychiatry Rep."},{"key":"1947_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4:409\u201318.","journal-title":"Lancet Psychiatry"},{"key":"1947_CR7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366.","journal-title":"Lancet"},{"key":"1947_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"1947_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","volume":"173","author":"J Sarris","year":"2016","unstructured":"Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, et al. Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry. 2016;173:575\u201387.","journal-title":"Am J Psychiatry"},{"key":"1947_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jep.2011.08.079","volume":"141","author":"Y Wang","year":"2012","unstructured":"Wang Y, Fan R, Huang X. Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. J Ethnopharmacol. 2012;141:571\u20137.","journal-title":"J Ethnopharmacol."},{"key":"1947_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0818-6","volume":"10","author":"SY Chan","year":"2020","unstructured":"Chan SY, Capit\u00e3o L, Probert F, Klinge C, Hoeckner S, Harmer CJ, et al. A single administration of the antibiotic, minocycline, reduces fear processing and improves implicit learning in healthy volunteers: analysis of the serum metabolome. Transl Psychiatry. 2020;10:148.","journal-title":"Transl Psychiatry"},{"key":"1947_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0466-x","volume":"9","author":"I Luki\u0107","year":"2019","unstructured":"Luki\u0107 I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O, et al. Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry. 2019;9:133.","journal-title":"Transl Psychiatry"},{"key":"1947_CR13","doi-asserted-by":"publisher","first-page":"104856","DOI":"10.1016\/j.phrs.2020.104856","volume":"157","author":"A Pascale","year":"2020","unstructured":"Pascale A, Marchesi N, Govoni S, Barbieri A. Targeting the microbiota in pharmacology of psychiatric disorders. Pharmacol Res. 2020;157:104856.","journal-title":"Pharmacol Res."},{"key":"1947_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-pharmtox-010617-052811","volume":"59","author":"TD Gould","year":"2019","unstructured":"Gould TD, Zarate CA Jr, Thompson SM. Molecular pharmacology and neurobiology of rapid-acting antidepressants. Annu Rev Pharmacol Toxicol. 2019;59:21\u201336.","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"1947_CR15","doi-asserted-by":"publisher","first-page":"104520","DOI":"10.1016\/j.phrs.2019.104520","volume":"150","author":"YS Wang","year":"2019","unstructured":"Wang YS, Shen CY, Jiang JG. Antidepressant active ingredients from herbs and nutraceuticals used in TCM: pharmacological mechanisms and prospects for drug discovery. Pharmacol Res. 2019;150:104520.","journal-title":"Pharmacol Res."},{"key":"1947_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/mp.2017.36","volume":"22","author":"MJ Ramaker","year":"2017","unstructured":"Ramaker MJ, Dulawa SC. Identifying fast-onset antidepressants using rodent models. Mol Psychiatry. 2017;22:656\u201365.","journal-title":"Mol Psychiatry"},{"key":"1947_CR17","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS. Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev. 2019;99:1819\u201375.","journal-title":"Physiol Rev."},{"key":"1947_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15:473\u201384.","journal-title":"Nat Rev Drug Discov."},{"key":"1947_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbi.2020.09.005","volume":"90","author":"Y Peng","year":"2020","unstructured":"Peng Y, Shi Z, Kumaran Satyanarayanan S, He C, Li P, Wan JB, et al. Fish oil alleviates LPS-induced inflammation and depressive-like behavior in mice via restoration of metabolic impairments. Brain Behav Immun. 2020;90:393\u2013402.","journal-title":"Brain Behav Immun."},{"key":"1947_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44052-2","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao J, Jung YH, Jin Y, Kang S, Jang CG, Lee J. A comprehensive metabolomics investigation of hippocampus, serum, and feces affected by chronic fluoxetine treatment using the chronic unpredictable mild stress mouse model of depression. Sci Rep. 2019;9:7566.","journal-title":"Sci Rep."},{"key":"1947_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0731-z","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang W, Wang T, Bai S, Chen Z, Qi X, Xie P. Dl-3-n-butylphthalide attenuates mouse behavioral deficits to chronic social defeat stress by regulating energy metabolism via AKT\/CREB signaling pathway. Transl Psychiatry. 2020;10:49.","journal-title":"Transl Psychiatry"},{"key":"1947_CR22","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1073\/pnas.1801609115","volume":"115","author":"C Nasca","year":"2018","unstructured":"Nasca C, Bigio B, Lee FS, Young SP, Kautz MM, Albright A, et al. Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci USA. 2018;115:8627\u201332.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1947_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jad.2019.11.147","volume":"263","author":"X Xie","year":"2020","unstructured":"Xie X, Yu C, Zhou J, Xiao Q, Shen Q, Xiong Z, et al. Nicotinamide mononucleotide ameliorates the depression-like behaviors and is associated with attenuating the disruption of mitochondrial bioenergetics in depressed mice. J Affect Disord. 2020;263:166\u201374.","journal-title":"J Affect Disord."},{"key":"1947_CR24","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1039\/C6NP00022C","volume":"33","author":"J Bisson","year":"2016","unstructured":"Bisson J, Simmler C, Chen SN, Friesen JB, Lankin DC, McAlpine JB, et al. Dissemination of original NMR data enhances reproducibility and integrity in chemical research. Nat Prod Rep. 2016;33:1028\u201333.","journal-title":"Nat Prod Rep."},{"key":"1947_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.aca.2020.10.038","volume":"1141","author":"MA W\u00f6rheide","year":"2021","unstructured":"W\u00f6rheide MA, Krumsiek J, Kastenm\u00fcller G, Arnold M. Multi-omics integration in biomedical research - a metabolomics-centric review. Anal Chim Acta. 2021;1141:144\u201362.","journal-title":"Anal Chim Acta"},{"key":"1947_CR26","doi-asserted-by":"publisher","first-page":"e1001871","DOI":"10.1371\/journal.pbio.1001871","volume":"12","author":"K Bozek","year":"2014","unstructured":"Bozek K, Wei Y, Yan Z, Liu X, Xiong J, Sugimoto M, et al. Exceptional evolutionary divergence of human muscle and brain metabolomes parallels human cognitive and physical uniqueness. PLoS Biol. 2014;12:e1001871.","journal-title":"PLoS Biol"},{"key":"1947_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/bib\/bbz055","volume":"21","author":"J Pu","year":"2020","unstructured":"Pu J, Yu Y, Liu Y, Tian L, Gui S, Zhong X, et al. MENDA: a comprehensive curated resource of metabolic characterization in depression. Brief Bioinform. 2020;21:1455\u201364.","journal-title":"Brief Bioinform."},{"key":"1947_CR28","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1038\/s41380-020-0645-4","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, et al. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry. 2021;26:4265\u201376.","journal-title":"Mol Psychiatry"},{"key":"1947_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9 M, Hruby A, Toledo E, Clish CB, Mart\u00ednez-Gonz\u00e1lez MA, Salas-Salvad\u00f3 J, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 2016;39:833\u201346.","journal-title":"Diabetes Care"},{"key":"1947_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.diabres.2018.03.045","volume":"140","author":"JE Park","year":"2018","unstructured":"Park JE, Lim HR, Kim JW, Shin KH. Metabolite changes in risk of type 2 diabetes mellitus in cohort studies: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2018;140:216\u201327.","journal-title":"Diabetes Res Clin Pract."},{"key":"1947_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2217\/BMM.15.39","volume":"9","author":"BA Rikke","year":"2015","unstructured":"Rikke BA, Wynes MW, Rozeboom LM, Bar\u00f3n AE, Hirsch FR. Independent validation test of the vote-counting strategy used to rank biomarkers from published studies. Biomark Med. 2015;9:751\u201361.","journal-title":"Biomark Med."},{"key":"1947_CR32","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1038\/s41380-021-01269-w","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J, Liu Y, Gui S, Tian L, Yu Y, Song X, et al. Metabolomic changes in animal models of depression: a systematic analysis. Mol Psychiatry. 2021;26:7328\u201336.","journal-title":"Mol Psychiatry"},{"key":"1947_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.15252\/emmm.201606798","volume":"8","author":"J Goveia","year":"2016","unstructured":"Goveia J, Pircher A, Conradi LC, Kalucka J, Lagani V, Dewerchin M, et al. Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities. EMBO Mol Med. 2016;8:1134\u201342.","journal-title":"EMBO Mol Med."},{"key":"1947_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0592-8","volume":"10","author":"A Khoruts","year":"2018","unstructured":"Khoruts A. Targeting the microbiome: from probiotics to fecal microbiota transplantation. Genome Med. 2018;10:80.","journal-title":"Genome Med"},{"issue":"6","key":"1947_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0893-133X(02)00377-9","volume":"27","author":"S Koch","year":"2002","unstructured":"Koch S, Perry KW, Nelson DL, Conway RG, Threlkeld PG, Bymaster FP. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology. 2002;27(6):949\u201359.","journal-title":"Neuropsychopharmacology"},{"key":"1947_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jad.2020.10.011","volume":"279","author":"GS Smith","year":"2021","unstructured":"Smith GS, Oeltzschner G, Gould NF, Leoutsakos JS, Nassery N, Joo JH, et al. Neurotransmitters and neurometabolites in late-life depression: a preliminary magnetic resonance spectroscopy study at 7T. J Affect Disord. 2021;279:417\u201325.","journal-title":"J Affect Disord."},{"key":"1947_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pscychresns.2017.08.009","volume":"269","author":"BP Brennan","year":"2017","unstructured":"Brennan BP, Admon R, Perriello C, LaFlamme EM, Athey AJ, Pizzagalli DA, et al. Acute change in anterior cingulate cortex GABA, but not glutamine\/glutamate, mediates antidepressant response to citalopram. Psychiatry Res Neuroimaging. 2017;269:9\u201316.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"1947_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-014-3687-y","volume":"232","author":"BR Godlewska","year":"2015","unstructured":"Godlewska BR, Near J, Cowen PJ. Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology. 2015;232:501\u20137.","journal-title":"Psychopharmacology"},{"key":"1947_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05121-6","volume":"7","author":"H Umehara","year":"2017","unstructured":"Umehara H, Numata S, Watanabe SY, Hatakeyama Y, Kinoshita M, Tomioka Y, et al. Altered KYN\/TRP, Gln\/Glu, and Met\/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder. Sci Rep. 2017;7:4855.","journal-title":"Sci Rep."},{"key":"1947_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00228-009-0650-7","volume":"65","author":"E K\u00fc\u00e7\u00fckibrahimo\u011flu","year":"2009","unstructured":"K\u00fc\u00e7\u00fckibrahimo\u011flu E, Saygin MZ, Cali\u015fkan M, Kaplan OK, Unsal C, G\u00f6ren MZ. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur J Clin Pharmacol. 2009;65:571\u20137.","journal-title":"Eur J Clin Pharmacol."},{"key":"1947_CR41","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.euroneuro.2016.08.007","volume":"26","author":"H de Morais","year":"2016","unstructured":"de Morais H, de Souza CP, da Silva LM, Ferreira DM, Baggio CH, Vanvossen AC, et al. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. Eur Neuropsychopharmacol. 2016;26:1590\u2013600.","journal-title":"Eur Neuropsychopharmacol."},{"key":"1947_CR42","doi-asserted-by":"publisher","first-page":"e0117503","DOI":"10.1371\/journal.pone.0117503","volume":"10","author":"S Gong","year":"2015","unstructured":"Gong S, Miao YL, Jiao GZ, Sun MJ, Li H, Lin J, et al. Dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice. PLoS ONE. 2015;10:e0117503.","journal-title":"PLoS ONE"},{"key":"1947_CR43","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","volume":"167","author":"V Krishnan","year":"2010","unstructured":"Krishnan V, Nestler EJ. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry. 2010;167:1305\u201320.","journal-title":"Am J Psychiatry"},{"key":"1947_CR44","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2020.19080848","volume":"177","author":"JB Dwyer","year":"2020","unstructured":"Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI, Carpenter LL, et al. Hormonal treatments for major depressive disorder: state of the art. Am J Psychiatry. 2020;177:686\u2013705.","journal-title":"Am J Psychiatry"},{"key":"1947_CR45","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","volume":"26","author":"W Marx","year":"2021","unstructured":"Marx W, McGuinness AJ, Rocks T, Ruusunen A, Cleminson J, Walker AJ, et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol Psychiatry. 2021;26:4158\u201378.","journal-title":"Mol Psychiatry"},{"key":"1947_CR46","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012;279:1356\u201365.","journal-title":"FEBS J"},{"key":"1947_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","volume":"127","author":"SJ Brown","year":"2021","unstructured":"Brown SJ, Huang XF, Newell KA. The kynurenine pathway in major depression: what we know and where to next. Neurosci Biobehav Rev. 2021;127:917\u201327.","journal-title":"Neurosci Biobehav Rev."},{"key":"1947_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbi.2020.04.016","volume":"88","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Sun Y, He Z, Xu Y, Li X, Ding J, et al. Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression. Brain Behav Immun. 2020;88:471\u201381.","journal-title":"Brain Behav Immun."},{"key":"1947_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.biopsych.2019.08.016","volume":"87","author":"M Bot","year":"2020","unstructured":"Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, et al. Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol Psychiatry. 2020;87:409\u201318.","journal-title":"Biol Psychiatry"},{"key":"1947_CR50","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.neuroimage.2010.10.017","volume":"54","author":"M Haris","year":"2011","unstructured":"Haris M, Cai K, Singh A, Hariharan H, Reddy R. In vivo mapping of brain myo-inositol. Neuroimage. 2011;54:2079\u201385.","journal-title":"Neuroimage"},{"key":"1947_CR51","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.mri.2010.06.019","volume":"28","author":"SY Kim","year":"2010","unstructured":"Kim SY, Choi CB, Lee HS, Lee SH, Woo DC, Kim HY, et al. Reversal of myo-inositol metabolic level in the left dorsolateral prefrontal cortex of rats exposed to forced swimming test following desipramine treatment: an in vivo localized (1)H-MRS study at 4.7 T. Magn Reson Imaging. 2010;28:1461\u20137.","journal-title":"Magn Reson Imaging"},{"key":"1947_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77\u201394.","journal-title":"Nat Rev Microbiol."},{"key":"1947_CR53","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1113\/JP276431","volume":"596","author":"M van de Wouw","year":"2018","unstructured":"van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O\u2019Sullivan O, et al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. J Physiol. 2018;596:4923\u201344.","journal-title":"J Physiol."},{"key":"1947_CR54","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3390\/nu10121939","volume":"10","author":"K Skonieczna-\u017bydecka","year":"2018","unstructured":"Skonieczna-\u017bydecka K, Grochans E, Maciejewska D, Szkup M, Schneider-Matyka D, Jurczak A, et al. Faecal short chain fatty acids profile is changed in polish depressive women. Nutrients. 2018;10:1939.","journal-title":"Nutrients"},{"key":"1947_CR55","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1017\/S000711451100674X","volume":"108","author":"JM Wallace","year":"2012","unstructured":"Wallace JM, McCormack JM, McNulty H, Walsh PM, Robson PJ, Bonham MP, et al. Choline supplementation and measures of choline and betaine status: a randomised, controlled trial in postmenopausal women. Br J Nutr. 2012;108:1264\u201371.","journal-title":"Br J Nutr."},{"key":"1947_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jad.2020.03.095","volume":"272","author":"Y Qu","year":"2020","unstructured":"Qu Y, Zhang K, Pu Y, Chang L, Wang S, Tan Y, et al. Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis. J Affect Disord. 2020;272:66\u201376.","journal-title":"J Affect Disord."},{"key":"1947_CR57","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","volume":"40","author":"Z Wang","year":"2019","unstructured":"Wang Z, Bergeron N, Levison BS, Li XS, Chiu S, Jia X, et al. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2019;40:583\u201394.","journal-title":"Eur Heart J"},{"key":"1947_CR58","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180:862\u2013877.e822.","journal-title":"Cell"},{"key":"1947_CR59","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.2337\/db11-0828","volume":"61","author":"Y Uchida","year":"2012","unstructured":"Uchida Y, Takeshita K, Yamamoto K, Kikuchi R, Nakayama T, Nomura M, et al. Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1. Diabetes. 2012;61:1552\u201361.","journal-title":"Diabetes"},{"key":"1947_CR60","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.4088\/JCP.v67n1114","volume":"67","author":"R Leo","year":"2006","unstructured":"Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry. 2006;67:1760\u20136.","journal-title":"J Clin Psychiatry"},{"key":"1947_CR61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aav0558","volume":"363","author":"PJ White","year":"2019","unstructured":"White PJ, Newgard CB. Branched-chain amino acids in disease. Science. 2019;363:582\u20133.","journal-title":"Science"},{"key":"1947_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopha.2016.12.024","volume":"86","author":"M Sivashanmugam","year":"2017","unstructured":"Sivashanmugam M, Jaidev J, Umashankar V, Sulochana KN. Ornithine and its role in metabolic diseases: an appraisal. Biomed Pharmacother. 2017;86:185\u201394.","journal-title":"Biomed Pharmacother."},{"key":"1947_CR63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/mp.2014.163","volume":"20","author":"PW Gold","year":"2015","unstructured":"Gold PW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry. 2015;20:32\u201347.","journal-title":"Mol Psychiatry"},{"key":"1947_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1128\/MMBR.00038-15","volume":"79","author":"LF Huergo","year":"2015","unstructured":"Huergo LF, Dixon R. The emergence of 2-oxoglutarate as a master regulator metabolite. Microbiol Mol Biol Rev. 2015;79:419\u201335.","journal-title":"Microbiol Mol Biol Rev."},{"key":"1947_CR65","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41574-020-0365-5","volume":"16","author":"L Kazak","year":"2020","unstructured":"Kazak L, Cohen P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Endocrinol. 2020;16:421\u201336.","journal-title":"Nat Rev Endocrinol."},{"key":"1947_CR66","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1007\/s12035-015-9580-9","volume":"53","author":"FL Pazini","year":"2016","unstructured":"Pazini FL, Cunha MP, Rosa JM, Colla AR, Lieberknecht V, Oliveira \u00c1, et al. Creatine, similar to ketamine, counteracts depressive-like behavior induced by corticosterone via PI3K\/Akt\/mTOR pathway. Mol Neurobiol. 2016;53:6818\u201334.","journal-title":"Mol Neurobiol."},{"key":"1947_CR67","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/aps.2017.207","volume":"39","author":"SJ Pan","year":"2018","unstructured":"Pan SJ, Tan YL, Yao SW, Xin Y, Yang X, Liu J, et al. Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression. Acta Pharmacol Sin. 2018;39:1463\u201372.","journal-title":"Acta Pharmacol Sin."},{"key":"1947_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00406-010-0164-4","volume":"261","author":"G Paslakis","year":"2011","unstructured":"Paslakis G, Gilles M, Lederbogen F, Schilling C, Scharnholz B, Deuschle M. The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients. Eur Arch Psychiatry Clin Neurosci. 2011;261:173\u20137.","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"1947_CR69","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4088\/JCP.08m04865blu","volume":"71","author":"AK van Reedt Dortland","year":"2010","unstructured":"van Reedt Dortland AK, Giltay EJ, van Veen T, van Pelt J, Zitman FG, Penninx BW. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2010;71:729\u201336.","journal-title":"J Clin Psychiatry"},{"key":"1947_CR70","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.psyneuen.2017.02.019","volume":"79","author":"RJT Mocking","year":"2017","unstructured":"Mocking RJT, Nap TS, Westerink AM, Assies J, Vaz FM, Koeter MWJ, et al. Biological profiling of prospective antidepressant response in major depressive disorder: associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity. Psychoneuroendocrinology. 2017;79:84\u201392.","journal-title":"Psychoneuroendocrinology"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01947-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01947-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01947-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:27:50Z","timestamp":1669231670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01947-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1947"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-01947-5","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"16 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}